tirzepatide clinicaltrials.gov Body weight reduction in women treated with by reproductive stage: a post hoc analysis from the SURMOUNT program Highlighting 3 ongoing clinical trials

For users who are gaining weight on tirzepatide , the situation may actually reflect muscle gain alongside fat loss, which is metabolically and sexually favorable even though the scale moves in an unexpected direction

Phase 2 obesity trial doses: 0.6 mg, 2.4 mg, 3.6 mg, and 4.8 mg once weekly

Whether I was gluten-free, dairy-free, or calorie counting, nothing worked

There are now more options available than ever, including Foundayo (orforglipron) a new oral GLP-1 pill approved in April 2026 that can be taken any time of day without food or water restrictions

Dose titration timing matters significantly

So which option is right for you